BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 A$
0,00%
(0,00) 1K
17-noy, 14:22:52 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
19,89 mln
Oʻrtacha hajm
10,87 mln
Hajmi
3,74 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
19,89 mln
Oʻrtacha hajm
10,87 mln
Hajmi
3,74 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
marketscreener.com
·
5 soat oldin
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
ChartMill
·
10 soat oldin
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
BigGo Finance
·
13 soat oldin
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
www.tokenpost.com
·
1 soat oldin
Defensive S&P 500 Sectors Outpace Nasdaq 100 by 26 Percentage Points
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida